Trasi, S. S., & Sashidharan, N. (2016). Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report. Asian Journal of Pharmaceutical and Clinical Research, 9(2), 12. Retrieved from https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/10418